![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 2, 1433-1442, January 11, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, October 26, 2001
Ly49A, an inhibitory C-type lectin-like mouse
natural killer cell receptor, functions through interaction with the
major histocompatibility complex class I molecule,
H-2Dd. The x-ray crystal structure of the
Ly49A·H-2Dd complex revealed that homodimeric
Ly49A interacts at two distinct sites of H-2Dd: Site 1, spanning one side of the NK1 cells provide a
crucial arm of the innate immune system as they are poised to respond
by cytolysis and lymphokine production to stimulation by neoplastic or
infected cells (1-3). NK cell activation is regulated by a balance of
activating and inhibitory signals delivered through receptors of the
immunoglobulin and C-type lectin-like superfamilies, that recognize
MHC-I or MHC-I-like molecules expressed on target cells (4). In resting
NK cells the inhibitory signals dominate, and perturbation of normal
expression of MHC-I, by viral infection or oncogenic dysregulation,
leads to attenuation of the inhibitory signal and augmentation of the activating one. The best understood inhibitory NK receptor of the
C-type lectin family is murine Ly49A, a type II membrane homodimer in
which the structure in complex with the MHC-I ligand,
H-2Dd, has been determined crystallographically (5). Direct
interaction of Ly49A with H-2Dd has been demonstrated in
cell adhesion and protein binding assays (6-9). In addition,
biotinylated Ly49A has been employed in staining the naturally
expressed H-2Dd ligand on normal cells (10, 11). Labeled
tetrameric MHC-I molecules including H-2Dd bind
specifically to various Ly49-expressing cells (12, 13). Although
Ly49A is a member of the C-type lectin superfamily, Ly49A-mediated recognition is Ca2+- and carbohydrate-independent and is
MHC-I-restricted but not peptide-specific (9, 14-16).
The crystal structure of the Ly49A·H-2Dd complex (5)
indicated that the Ly49A homodimer interacts with two topographically distinct sites on H-2Dd (Fig. 1a). At Site 1, a
single Ly49A subunit contacts one end of the MHC-I peptide-binding
groove, involving the amino terminus of the To resolve the issue as to whether Site 1 or Site 2 plays the major
role, we have exploited a well defined biochemical system using only
recombinant, highly purified molecules. Using a panel of site-directed
mutants of Ly49A, H-2Dd, and Mutagenesis of Ly49A, H-2Dd, and Mouse
Protein Expression--
Bacteria harboring either the parental
or mutant Ly49A-, H-2Dd-, or
Monoclonal Antibodies and Recombinant Protein
Ligands--
Monoclonal antibodies used in BIAcore binding assays
were: A1, specific for Ly49AC57BL/6 (29, 30), YE1-32, and
YE1-48 (derived in rat) (31, 32), and JR9-318 (derived from Mus
spretus) (33), which binds all allelic forms of Ly49A. The
anti-Ly49G2 mAb 4D11 is described by Mason et al. (34).
Anti-Ly49C/I-reactive SW5E6 (35) was used as control for Ly49A binding.
mAbs 34-2-12 (anti-H-2Dd Surface Plasmon Resonance Binding Assays--
Assays for binding
of Ly49A, H-2Dd, and mAbs were based on kinetic progress
curves obtained with the BIAcore 2000 using methods employed previously
(9, 40). In general, one ligand (either a mAb, Ly49A, or scTCR) was
immobilized on a CM5 biosensor chip using standard coupling procedures,
and solution phase ligand (analyte) was offered at a flow rate of 10 µl/min. All binding experiments were performed at 25 °C. A
mock-coupled surface that was activated and blocked but had no protein
immobilized was always included as a control for nonspecific binding.
When Ly49A mutants were evaluated, a Ly49A wild type-coupled surface
was included on the same chip for direct comparison. Kinetic data were
collected and analyzed using BIAevaluation 3.1 to calculate kinetic
association and dissociation rate constants and equilibrium constants
for dissociation. In all cases the potential for sequential
deterioration of the integrity of the solid phase ligand was evaluated
periodically with appropriate controls introduced throughout the run.
Binding parameters obtained by kinetic analysis were compared with
equilibrium parameters calculated in parallel and were always
internally consistent.
Interface Mutants of the Ly49A Homodimer--
To evaluate the
contribution of particular residues of Ly49A to recognition by
H-2Dd, as well by specific monoclonal antibodies (mAbs), we
made individual alanine substitutions at those positions that, in the
crystal structure, appeared crucial to either the homodimeric
interaction or the interaction between H-2Dd and Ly49A
(Fig. 1). Six Ly49A interface residues,
Tyr142, Trp143, Phe144,
Tyr146, Leu188, and Val189 were
mutated, and the bacterially expressed mutant proteins were tested for
binding to bacterially expressed H-2Dd as well as to a
panel of anti-Ly49 mAbs. Although several mutants showed decreased
binding to some of the mAbs tested, all preserved the capacity to
interact with several at levels at least 50% that of controls (Fig.
2a). Binding to 4D11, which
primarily recognizes Ly49G2 and has weak activity on Ly49A, was lower
for mutants at positions 142, 143, 146, and 189. Interestingly, 4D11
reactivity was greater for mutants at positions 144 and 188. Significantly, mutation at positions 142, 143, 146, and 189 each
revealed decreased binding to either of the H-2Dd
preparations (Fig. 2b). These results suggest that the
integrity of the homodimer is important for binding to the MHC-I ligand and also influences binding by some mAbs.
Site 2 and Site 1, 2 Mutants of Ly49A--
Next, we examined
mutants of Ly49A at H-2Dd contact sites. However, no
contact residues of Ly49A are unique to Site 1, and therefore any
mutation would either include both Sites 1 and 2 or be unique to Site
2. We first studied mutants at Site 2, the interface between Ly49A and
H-2Dd that involves Ly49A and all three domains of
H-2Dd as well as its light chain,
We then analyzed seven mutants that represented contacts at both Sites
1 and 2: D229A, D241A, N242A, D246A, Q247A, V248A, and F249A (Figs.
1-3). D229A, although it revealed little or no effect on binding of
any of the mAbs, eliminated interaction with H-2Dd. D241A,
which profoundly reduced binding to A1 but had little effect on any
other mAb, also affected binding to H-2Dd, most
significantly with an increase in the kd from 0.054 to 0.363 s Surface Representation of Ly49A Site 2 and Site 1, 2 Mutant
Effects--
To visualize the location of those Ly49A residues that
influence H-2Dd and mAb interaction, we generated a surface
representation of their effect on binding (Fig.
4; Ly49A interface mutants are not seen
in such a display). Mutations that adversely affected binding are
colored in red, orange, yellow, and green,
whereas those that improved binding, presumably by eliminating a
negative effect, are depicted in light blue and
blue. The residues that most affected A1 binding
(Lys224, Asp241, and Arg239) form a
contiguous patch on the surface of the molecule (Fig. 4a).
Residues Asp229, Ser236, and Thr238
neighbor this region, and it is straightforward to imagine that the
antibody-combining site of A1 could overlay this set of residues on one monomer of the Ly49A homodimer. A1 is an alloantibody raised in
BALB/c mice against Ly49AC57BL/6 (29). Allelic differences
between Ly49ABALB/c and Ly49AC57BL/6 in the
region where the Ly49AC57BL/6 structure is known are at
positions 187 and 238 (where Ly49AC57BL/6 has Gln and Thr,
respectively, and Ly49ABALB/c has His and Ile). Residue 187 lies adjacent to residue 238 on the surface of Ly49A. In contrast to
those residues in which mutation adversely affected the binding of A1,
mutants N203A, Q247A, V248A, and F249A improved binding by A1.
The binding of three other antibodies, YE1/48, YE1/32, and JR9-318, to
the panel of mutants reveals different characteristics. The only
mutation that adversely affects binding of YE1/48 is K224A (Fig.
4c); YE1/32 is most affected by D246A (Fig. 4d);
and JR9-318 is most dependent on K224 (Fig. 4f). These
results suggest that YE1/32 interacts more with residues on the
"side" of the Ly49A molecule than with those on the "top."
The surface region that most affects H-2Dd binding is a
large area that extends from Asp246 across the top of the
molecule that includes Gln247, Val248,
and Phe249 as well as a distinct surface consisting of
Asp229, Ser236, Thr238,
Arg239, Asp241, and Asn242 (Fig. 4,
b and e). In addition to the adverse effects of
mutation of any of the residues in this patch, mutation of
Asn203 and Lys224 to alanine improves the
binding to H-2Dd molecules. Thus, the focus of
H-2Dd binding is on Arg239 and the surrounding
residues located along the top of Ly49A.
The Importance of Site 2 Mutants of H-2Dd and
To test the contribution to binding of these potential contact regions,
we produced alanine mutations at all seven positions: two at Site 1 of
the H-2Dd heavy chain (Q54A and R169A); three at Site 2 (Y85A, N86A, and D122A); and two at the
Although H-2Dd mutant D122A and
To explain the profound effects exerted by mutation of
H-2Dd D122A, as well as Our mutational analysis of the binding of Ly49A,
H-2Dd, and The importance of Site 2 is indicated by the effect of mutations in
Ly49A unique to Site 2 (in particular residues Ser236,
Thr238, and Arg239) as well as by mutation of
H-2Dd (Asp122) (Fig. 7b) and
The analysis of the regions of importance in Site 2 recognition clearly
implicates the organization of water molecules in this large and
imperfect interface in mediating the interaction between Ly49A and
H-2Dd (Fig. 7). We speculate that the binding specificity
of the Ly49 molecules for their MHC/peptide ligands is influenced by a
water network exemplified in the Ly49A·H-2Dd
structure by residues Asp122 of H-2Dd
with Ly49A·residues Ser236, Lys237,
Thr238, and Arg239; Lys58 of
The accumulation of the mutational evidence clearly reveals effects of
H-2Dd residue Asp122 and In summary, our mutational analysis of Ly49A has permitted the
localization not only of the sites bound by each of a panel of mAbs but
has also demonstrated conclusively the importance of the homodimer
interface and has localized the critical site of interaction between
Ly49A, H-2Dd, and We thank W. M. Yokoyama
(Washington University, St. Louis, MO) for providing hybridoma cells
and encouragement. We thank J. Dorfman and M. Lenardo for their
comments on the manuscript.
*
This work was supported in part by National Institutes of
Health Grants AI47900 and GM52801 (to R. A. M.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This paper is dedicated to the memory of José Tormo, colleague
and friend.
Published, JBC Papers in Press, November 5, 2001, DOI 10.1074/jbc.M110316200
2
N. Dimasi, M. W. Sawicki, L. N. Reineck, Y. Li, K. Natarajan, D. H. Margulies, and R. A. Mariuzza, manuscript in preparation.
The abbreviations used are:
NK, natural killer;
Binding of the Natural Killer Cell Inhibitory
Receptor Ly49A to Its Major Histocompatibility Complex Class I
Ligand
CRUCIAL CONTACTS INCLUDE BOTH H-2Dd AND
2-MICROGLOBULIN*
,
,
,
Molecular Biology Section, Laboratory of
Immunology, NIAID, National Institutes of Health, Bethesda, Maryland
20892-1892, § Campus de la Universidad Autonoma de Madrid,
28049 Madrid, Spain, and ¶ Center for Advanced Research in
Biotechnology, University of Maryland Biotechnology Institute,
Rockville, Maryland 20850
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1 and
2 helices, and Site 2, involving
the
1,
2,
3, and
2m domains. Mutants of Ly49A, H-2Dd, and
2-microglobulin at intermolecular
contacts and the Ly49A dimer interface were examined for binding
affinity and kinetics. Although mutations at Site 1 had little affect,
several at Site 2 and at the dimer interface hampered the
Ly49A·H-2Dd interaction, with no effect on gross
structure or T cell receptor interaction. The region surrounding the
most critical residues (in H-2Dd,
Asp122; in Ly49A, Asp229,
Ser236, Thr238, Arg239, and
Asp241; and in
2-microglobulin,
Gln29 and Lys58) of the
Ly49A·H-2Dd interface at Site 2 includes a network of
water molecules, suggesting a molecular basis for allelic specificity
in natural killer cell recognition.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1 helix and the carboxyl
terminus of
2. Site 2 is a concavity beneath the peptide-binding
platform, bounded by amino acid residues of the floor of the
sheet
of the
1 and
2 domains, as well as by the
3 domain and the
MHC-I light chain,
2m. This site overlaps the region
where CD8
interacts with MHC-I (5). In attempts to understand the
details of the interaction of Ly49 receptors with their MHC-I ligands,
several groups have analyzed binding and recognition using cells
transfected with recombinant Ly49 molecules (17, 18), MHC-I mutants in
transfected cells (16, 19-22), and binding of recombinant Ly49A to
cells derived from different mouse inbred strains (10, 11). These
studies suggest that amino acids in the "neck" region of Ly49A (17) or Ly49C (18), residues of both Site 1 of H-2Dd (10) and
Site 2 (22), as well as of its peptide-binding grove (20, 21) may all
contribute either directly or indirectly to the Ly49A/MHC-I
interaction. In addition, two groups have reported the effects of human
2m on the Ly49A/MHC-I interaction (22, 23). Thus,
although some evidence supports Site 1 as a primary region of
interaction between MHC-I and Ly49A, other experiments are more
consistent with Site 2 playing the predominant role, and some studies
are inconclusive.
2m in binding
assays, we have determined kinetic and equilibrium parameters
quantitatively. These data, viewed in the context of the crystal
structure of the Ly49A·H-2Dd complex, define not only the
dominant site of interaction of Ly49A with its MHC-I ligand as Site 2, but also provide insight into the importance of homodimeric interaction
in maintaining the integrity of Ly49A. Inspection of the region of
intermolecular contact at Site 2 reveals important contributions from a
network of water molecules coordinated by Ly49A, H-2Dd, and
2m residues and helps to explain the allelic specificity and peptide preference that particular members of the Ly49 family exhibit.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
2m--
Mutants were generated by site-directed
mutagenesis of the codons of interest to encode alanine substitutions.
Using Stratagene's QuickChange Mutagenesis Kit and following the
manufacturer's instructions, mutations were introduced into: 1) a
cDNA construct encoding the entire extracellular region (residues
67-262) of the C57BL/6 allele of Ly49A in a bacterial expression
vector (pET21a; Novagen) (9); 2) a cDNA construct encoding the
mature extracellular residues of H-2Dd in pET3a (24); or 3)
a murine
2m-encoding construct based on the C57BL/6
allele of
2m in pET21d (25). Mutations were confirmed by
automated DNA sequencing analysis using an ABI 377 DNA sequencer and
accompanying sequencing analysis software (PerkinElmer Life Sciences).
Escherichia coli strain BL21(DE3) was transformed with these
mutant plasmid DNAs for protein expression.
2m-encoding plasmid vectors were cultured in LB broth
containing 0.25 mg/ml carbenicillin and, following induction of
exponentially growing cells for 2 h with
isopropyl-1-thio-
-D-galactopyranoside, were lysed
with 0.5 mg/ml of hen egg white lysozyme overnight at 4 °C and then
with 0.1% deoxycholate for 30 min. The resulting inclusion bodies were
washed first with 0.1% deoxycholate in TE buffer (0.1 M
Tris pH 8.0, 2 mM EDTA) and then extensively with TE, and
they were then denatured in 6 M guanidine hydrochloride and
reduced with 0.1 mM dithiothreitol. Ly49A was refolded
following dilution into an arginine buffer (0.4 M
L-arginine-HCl, 0.1 M Tris, pH 8, 2 mM EDTA, 3 mM reduced glutathione, and 0.3 mM oxidized glutathione). Following dialysis against 25 mM MES, pH 5.5, protein was further purified by ion
exchange chromatography (Mono-S) followed by gel filtration on a
Superdex 75 column. H-2Dd was prepared similarly, with
refolding taking place in the presence of mouse
2m and
either a motif (AGPARAAAL) peptide (26) or the HIV IIIB envelope gp160
peptide, P18-I10 (RGPGRAFVTI) (27, 28). Refolded proteins were
further purified by size exclusion chromatography on Superdex-75
(Amersham Biosciences, Inc.).
3 domain) and 34-5-8 (anti-H-2Dd
1/
2 domain) (36, 37) were from PharMingen
(San Diego, CA). KP15, a mAb specific for H-2Dd bound to
the HIV envelope glycoprotein-derived peptide
Pro18-Ile10, has been described elsewhere (38).
All antibodies were used as purified proteins. A single-chain TCR
(scTCR) with specificity for
H-2Dd/Pro18-Ile10 was expressed in
E. coli and purified as described previously (39).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (36K):
[in a new window]
Fig. 1.
Location of contacts between Ly49A and
H-2Dd. a, a ribbon diagram of the structure
of the Ly49A·H-2Dd complex (Protein Data Bank code 1qo3)
showing sites of interaction. These are referred to as Site
1, Site 2, and Ly49A homodimer interface
(labeled only on one dimer). The subunit designations are:
A, H-2Dd heavy chain; B,
2m; C, Ly49A subunit at Site 1; D,
dimeric partner of C; E, symmetry-related Ly49A
subunit C; F, major Ly49A subunit interacting at Site 2. The
C
atoms of residues of the homodimer interface (orchid),
Site 2 alone (magenta), and Sites 1 and 2 (orange-red) are indicated as space-filled
spheres. b, Ly49A amino acid sequence and location of
residues selected for mutagenesis. The amino acid sequence of
Ly49AC57BL/6 is shown with the transmembrane region (amino
acids 45-66) and the lectin-like domain (amino acid 141-262) enclosed
in boxes. Secondary structure elements are labeled, and the
positions of site-directed mutants are indicated: interface contacts of
the homodimer (filled circles, orchid), Site 1 and Site 2 (orange-red downward arrows), and Site 2 unique
(magenta upward arrows).

View larger version (43K):
[in a new window]
Fig. 2.
Binding of mAbs and H-2Dd to
Ly49A and its site-directed mutants. a, from 4200 to
6000 resonance units of Ly49A and the indicated mutant proteins were
coupled to biosensor chips and tested for binding to different specific
mAbs. b, Ly49A mutants were tested for binding to
H-2Dd/motif and
H-2Dd·Pro18-Ile10 complexes at a
concentration of 6.5 µM. The Relative Binding,
corrected for background binding to a mock-coupled surface and for
level of coupling of the solid phase reagent, was compared with binding
to a wild type Ly49A surface and was calculated as follows.
Resonance unit (RU) levels are at steady
state. Relative binding (RB) of Ly49A wild type
therefore = 1. Open bar, Ly49A wild type
(WT); solid bar, control mutant S113A;
back-slashed bar, interface mutants; gray bar,
Site 2 mutants alone; forward slashed bar, Site 1 and Site 2 mutants. c, relative binding of Ly49A mutants to mAbs and to
H-2Dd was calculated as described above.
JR9-318, a mAb that binds several Ly49
molecules, was derived from M. spretus, and we might expect
the Ly49 molecules of this strain to lack Lys224. We also
tested SW5E6, which recognizes Ly49C and Ly49I but not Ly49A (54). In
surface plasmon resonance analysis SW5E6 failed to bind Ly49A and also
showed no binding to the full panel of Ly49A mutants (data not
shown).
2m (Fig.
1a). For H-2Dd binding, point mutations
generally either improved binding (N203A and K224A) or impaired binding
significantly (S236A, T238A, and R239A). S236A and R239A showed an
undetectable level of binding to H-2Dd, and T238A
quantitatively reduced binding by about 9-fold (KD increasing from 1.82 to 15.9 µM largely as a result of
kd increasing from 0.063 to 0.363 s
1
(Fig. 3b)). The behavior of
the triad of Ser236, Thr238, and
Arg239 clearly indicates the importance of Site 2 interactions in H-2Dd binding. Binding to a panel of mAbs
indicated that the overall integrity of the mutants was preserved and
also allowed mapping of epitopes recognized by particular mAbs (Fig.
2). Mutants of N203A, K224A, S236A, T238A, and R239A revealed
differences in binding to some of the mAbs. In particular, N203A showed
augmented binding to A1, YE1/32, and YE1/48, had no effect on binding
to JR9-318, and showed absolutely no binding to 4D11. K224A reduced binding to A1, YE1/48, and JR9-318 and increased binding to YE1/32. Mutants S236A, T238A, and R239A modestly decreased binding to A1, and
R239A increased binding to YE1/32, YE1/48, and 4D11.

View larger version (30K):
[in a new window]
Fig. 3.
H-2Dd binding to Ly49A
mutants. a, H-2Dd·motif and
H-2Dd·P18-I10 were injected at five different
concentrations ranging from 0.5 to 8 µM in 2-fold
increments over biosensor surfaces coupled with different Ly49A
mutants. Each row represents a binding assay performed on different
flow cells of the same CM5 chip. Because the binding patterns of
H-2Dd·motif and
H-2Dd·Pro18-Ile10 preparations
were similar, but the level of
H-2Dd·Pro18-Ile10 binding was
lower, we show only H-2Dd·motif-binding curves.
b, experimental sensorgram data were obtained from binding
curves of experiments similar to panel a, and kinetic
evaluation was performed using BIAevaluation 3.1. Analysis employed a
1:1 binding model that included a correction for drifting base line.
The different groups represent five independent experiments using
different biosensor chips. t1/2 was calculated
according to the relationship t1/2 = 0.693/kd. ND, nondetectable;
WT, wild type.
1 (Fig. 3). N242A modestly reduced binding to
YE1/32 and 4D11 and also impeded interaction with H-2Dd.
D246A, which adversely affects binding of YE1/32 and 4D11, also showed
quantitative effects on binding to H-2Dd. Other mutations
of residues that structurally contribute at both Sites 1 and 2, Q247A
and F249A, did not impede mAb binding and augmented it in some cases.
V248A impaired recognition by YE1/32. These three mutants showed
quantitative effects on binding to H-2Dd/P18-I10 but less
pronounced effects when assayed with H-2Dd·motif
complexes. The most consistent of the effects observed was with F249A,
which showed a slight increase in ka, a marked (more
than 5-fold) increase in the kd, and a 5-fold
increase in KD (Fig. 3b).

View larger version (76K):
[in a new window]
Fig. 4.
Molecular surface representation of Ly49A
mutations affecting binding by H-2Dd and mAb. Ly49A
Site 2 and Site 1, 2 mutants with different binding effects were
visualized in a surface representation of the structure of Ly49A. The
binding of A1 (a), YE1/32 (d), YE1/48
(c), JR9-318 (f), and H-2Dd/motif
(b and e) is based on the BIAcore binding
analysis as shown in Fig. 2. This illustration was rendered with GRASP
1.3.6 (55). The extent of binding of each of the alanine mutants is
color-coded according to the values given in the legend for Fig.
2c. The following color scale was used, with red
representing the lowest level of binding and blue the
highest: red, relative binding
0.05;
orange, 0.05 < relative binding
0.1;
yellow, 0.1 < relative binding
0.5;
green, 0.5 < relative binding
1.0; light
blue, 1.0 < relative binding
1.5; blue,
1.5 < relative binding
2.0.
2m--
Although the behavior of Ly49A mutants S236A,
T238A, and R239A strongly suggested that Site 2 was the major focus of
the Ly49A/H-2Dd interaction, other data, including the
analysis of polymorphic MHC-I residues in different mouse strains and
the behavior of a single H-2Dd mutation of I52M, had
suggested that Site 1 was important (10). To clarify this issue, we
tabulated the number of atomic contacts between those residues that
seemed to be most involved in binding to H-2Dd (Table
I). We looked closely at the contacts
made by Ly49A residues Asp229, Ser236,
Thr238, Arg239, Asp241,
Asn242, Gln247, Val248, and
Phe249 at either Site 1 or Site 2. For Site 1 contacts,
Gln247, Val248, and Phe249 made 18 atomic contacts with residue Gln54 of H-2Dd,
and residue Asp229 made 10 contacts with H-2Dd
residue Arg169. For Site 2 contacts, the greatest number
(23) were made by Ly49A residues Ser236,
Thr238, and Arg239 to Asp122 of
H-2Dd. These contacts are specifically between the "F"
subunit of Ly49A and H-2Dd. Ly49A residues
Thr238, Arg239, and Asp241 are
ambiguous, however, in that those residues in the "E" subunit (Fig.
1a and Table I) also make contact with H-2Dd
residues Tyr85 (8) and Asn86 (10). Residues
Gln247, Val248, and Phe249 of Ly49A
made 21 contacts with
2m residue Gln29; and
residues Asp229, Arg239, Asp241,
and Asn242 of Ly49A made 20 contacts with
2m
residue Lys58.
Atomic contacts between Ly49A and H-2Dd residues
2m contact (Q29A
and K58A). In addition, a non-contact mutant in H-2Dd,
S246A, was generated as a control. Each of these eight mutants in
parallel with a parental H-2Dd·motif peptide complex was
tested by surface plasmon resonance for binding to Ly49A. The
sensorgrams and the steady state levels of binding are plotted as a
function of analyte concentration in Fig.
5. The mutational analysis of
H-2Dd and
2m clearly implicates Site 2 as
the major determinant of the Ly49A·H-2Dd binding
interaction: H-2Dd mutant D122A and
2m
mutants Q29A and K58A had profound effects on binding to Ly49A. (In
addition, these two
2m mutants exerted no effect on the
binding of a
2m-dependent mAb, S19.8, over a wide range of concentration. S19.8 also showed
concentration-dependent inhibition of binding of
H-2Dd to Ly49A even when the H-2Dd was
complexed with either of the two
2m mutants (data not
shown).) In contrast to the effects of Site 2 mutants of
H-2Dd, those at Site 1, Q54A and R169A, showed little
effect on binding. Two mutants at the periphery of Site 2, Y85A and
N86A, and the S246A control showed only a small quantitative
effect.

View larger version (37K):
[in a new window]
Fig. 5.
H-2Dd and
2m mutant binding to Ly49A. The
interactions between mutants of H-2Dd,
2m,
and wild type Ly49A were measured in the BIAcore binding assay. Ly49A
and mAbs specific for H-2Dd were immobilized on a
CM5 chip as described under "Experimental Procedures." Wild
type (WT) H-2Dd or its mutants refolded with
motif peptide were measured at concentrations from 0.156 to 10 µM in 2-fold increments. Resonance unit (RU)
values are corrected for background binding. a and
b, data from two different experiments. c and
d, dose-dependent response comparison of binding
of different H-2Dd mutants and
2m mutants to
Ly49A. All preparations were tested in parallel for binding to
anti-H-2Dd mAb to confirm the concentration as determined
by UV absorbance and the preservation of serological activity (data not
shown).
2m mutants
Q29A and K58A severely reduced binding to Ly49A, they retained the
ability to bind to H-2Dd-specific mAbs 34-35-8 and 34-2-12 (data not shown). To eliminate the possibility that these mutations may
have distorted either the peptide binding site or the TCR binding site
of the molecule, we tested their ability to interact with both an
H-2Dd/Pro18-Ile10-restricted
specific recombinant scTCR and with an MHC-restricted, peptide-specific
mAb, KP15 (38). As shown in Fig. 6, the
three mutants and the parental
H-2Dd/Pro18-Ile10 bind both the
scTCR and KP15 equivalently. These results reinforce the view that the
Ly49A binding site on H-2Dd is distinct from that of the
TCR.

View larger version (22K):
[in a new window]
Fig. 6.
Binding of different
H-2Dd·peptide/
2m
complexes to scTCR. H-2Dd mutant D122A and
2m mutants Q29A and K58A, which were assembled
with parental H-2Dd and with peptide
Pro18-Ile10, were analyzed in a
dose-dependent manner for binding to: a, scTCR,
0.6-10 µM; b, mAb KP15, 0.015-0.5
µM; c, Ly49A, 0.6-20 µM (these
were also compared with H-2Dd/motif binding in all cases).
All preparations were also tested for binding to mAbs 34-2-12 and
34-5-8 in a similar fashion (data not shown).
2m Q29A and K58A, we
returned to a close inspection of the interface of H-2Dd
with Ly49A at Site 2 (Fig. 7). In
particular, we have included the water molecules at this interface. The
region that surrounds residue Asp122 of H-2Dd
reveals not only the proximity of the side chains of residues Ser236, Thr238, and Arg239 of Ly49A
but also at least seven water molecules that are involved in this
interface (Fig. 7b). The
2m residue
Lys58, which is highly conserved among species, interacts
with Asp229, Asp241, and Asn242 of
Ly49A amid a network of water molecules that also coordinate with the
side chain of H-2Dd residue Arg6 as well as
Arg239 (Fig. 7c). Continuing this general trend,
2m residue Gln29 (the Gln is unique to mouse
2m) not only interacts with its contact residues
Gln247, Val248, and Phe249 on Ly49A
but also interacts with a number of waters in this vicinity (Fig.
7d).

View larger version (55K):
[in a new window]
Fig. 7.
H-2Dd residue Asp122
and
2m residues Gln29
and Lys58 interact with Ly49A at Site 2. Interactions
of residues in H-2Dd·Ly49A complex (Protein Data Bank
code 1qo3) were illustrated with MOLSCRIPT (56) and rendered with
Raster3d (42). a, interaction between Ly49A (F domain),
H-2Dd, and
2m mutants at Site 2. b, side-by-side stereo view of network of interactions of
H-2Dd residue Asp122 and Ly49A residues
Ser236, Lys237, Thr238, and
Arg239 in the presence of water molecules.
Asp122 of H-2Dd contacts directly with
Ser236, Thr238, and Arg239 of Ly49A
through hydrogen bonds. c, side-by-side stereo view of
network of
2m residue Lys58 with Ly49A
residues Asp229, Asp241, and Asn242
in the presence of water molecules. d, side-by-side stereo
view of network of
2m residue Gln29 with
Ly49A residues Gln247, Val248, and
Phe249 in the presence of water molecules. Dashed
lines indicate hydrogen bonds. Other atomic contacts are not
explicitly shown. Yellow, H-2Dd;
blue, Ly49A; lavender,
2m;
orange spheres, water molecules.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
2m mutants leads to two major
conclusions: that the primary binding site of H-2Dd
employed by Ly49A is at Site 2, a large surface area that involves contacts from the floor of the peptide-binding groove of the MHC-I and
residues from
2m; and that integrity of the Ly49A
homodimer is critical for preservation of MHC-I binding. The effect of
mutation of the homodimeric interface residues
Tyr142, Trp143, Tyr146, and
Val189 in reducing binding to H-2Dd as well as
the augmentation of binding by mutations of Phe144 and
Leu188 suggest that the structure of the surface that
contacts H-2Dd is influenced by the nature of the
homodimerization. These results are of particular importance when we
consider the three-dimensional structure and mode of
dimerization of NK receptors and related molecules. As found
previously (41), the dimer interfaces of Ly49A, NKG2D,
and CD69 are highly conserved, although in Ly49A it is somewhat
asymmetric, whereas NKG2D and CD69 show clear symmetry. The recently
determined structure of Ly49I indicates that even within the Ly49
family there is considerable flexibility in the dimerization, because
in this molecule the
2 helix is not involved in the dimer
interface.2 These NK receptor
domains dimerize differently from other more distantly related members
of the C-type lectin family such as tunicate lectin and coagulation
factor IX binding protein. In an evaluation of the binding of
Ly49CC57BL/6 and Ly49IC57BL/6 to various MHC-I
molecules in a cell agglutination assay, Lian et al. (18)
observed that mutation of Tyr146 (the position equivalent
to Tyr142 of Ly49A) of Ly49C to the histidine found in the
closely related Ly49I resulted in reduced binding to H-2s
and H-2b cell lines as well to an H-2Dd
transfectant. These results suggest that variability in the mode of
dimerization influences allelic specificity of Ly49 family members.
2m (Gln29 and Lys58 (Fig. 7,
d and c)). Ly49A is unique among NK receptors of
either the Ig-like or C-type lectin-like families in its utilization of
the
2m subunit as part of its binding site. A mutational
analysis of H-2Dd, based on transfection and agglutination
and functional assays, indicated an important role for
residues Arg6, Asp122, and Lys243
of H-2Dd (22), and the importance of species differences in
2m has been reported (22, 23). Our results add
unequivocal data indicating the critical importance of the two major
contact residues of
2m. This analysis also implicates
2m as a spatial transducer of subtle structural changes
that occur either in the peptide-binding groove or in other parts of
the
1
2 unit of the MHC heavy chain. The disposition of
2m with respect to the heavy chain varies markedly in
different crystal structures (24, 43, 44), and the stability of the
MHC/
2m interaction is affected by amino acid
substitutions in the peptide-binding groove (45). The exquisite
sensitivity of Ly49A binding to substitution of either of the two major
2m contact residues, Gln29 or
Lys58, explains the observed effects of substitution of
bovine or human
2m in NK recognition (22, 23), because
position Gln29 is unique to murine
2m,
whereas human and bovine variants have glycine. The effect of
2m dislocation at the Site 2 interface explains the
behavior of two mutations of H-2Dd, D29N and R35A, that
affect Ly49A binding without direct involvement of the Site 2 interface
(21). Mutant D29N would be expected to have an indirect effect on
2m binding because it interacts primarily with H3 of
H-2Dd and only indirectly with
2m residue
Arg228. Residue Arg35 is involved in hydrogen
bonds to
2m M54 backbone oxygen as well as to
H-2Dd E32. Thus, mutation of Arg35 to Ala would
be expected to change the affinity of the MHC heavy chain for
2m and distort the disposition of this subunit, thereby altering the interaction with Ly49A. Several other substitutions of
H-2Dd that do not make direct contact with either Ly49A or
2m have been studied, and their behaviors may be
explained by similar distant effects. In particular, the double mutant
S73W,D156Y, comprising residues that line the peptide-binding
groove, has been shown to have functional effects on NK recognition
(20), and the double mutants D77S,A99F and N30D,A99F as well as the triple mutant N30D,D77S,A99F showed reduced binding in an Ly49A tetramer staining assay (21). Residues Ser73,
Asp77, Ala99, and Asp156 play a
role in peptide interaction and thus are likely to contribute to the
stability of the interaction with
2m, thereby affecting the interaction with Ly49A. The nature of the N30D substitution, which seems synergistic with substitution of peptide binding cleft residues, probably is due to the role that N30D plays in the
interaction with Ly49A via distant interaction with residue R228 of
2m. In addition to these experiments with mutant
H-2Dd and
2m, our earlier studies examining
the behavior of a single-chain
2m/H-2Dd
molecule in NK cell recognition are also consistent with Ly49A interacting primarily with a site distinct from that of the TCR and
subject to inhibition by the peptide linker extending from the carboxyl
terminus of
2m to the amino terminus of
H-2Dd (10, 46). Because Ly49G2, a molecule related to Ly49A
in both sequence and in its ability to interact with H-2Dd,
also is incapable of interacting with the single-chain
2m/H-2Dd molecule (46), it is likely that
Ly49G2 binds H-2Dd at the same site as Ly49A. (Comparison
of amino acid sequences of Ly49AC57BL/6 and
Ly49G2C57BL/6 reveals that the residues that contact
Asp122 of H-2Dd and Lys58 of
2m in the Ly49A complex are conserved, whereas those
that interact with the conserved Gln29 of
2m
are polymorphic.)
2m along with Arg6 of H-2Dd and
Asp229, Arg239, Asp241, and
Asn242 of Ly49A; and Gln29 of
2m
with Asp59 of
2m, and Gln247,
Val248, and Phe249 of Ly49A. Since the
description of an important role for water in the carbohydrate
specificity of the L-arabinose-binding protein (47), there
has been considerable interest in the contribution of water to ligand
specificity (48). Recently water has been shown to be important in the
specific binding of peptides to MHC molecules (49-53).
2m
residues Gln29 and Lys58 on Ly49A binding.
These effects seem to be local rather than global, because the TCR
binding site of the
H-2Dd·Pro18-Ile10 complex was
preserved both for direct interaction with a cognate TCR and for
binding by an MHC-restricted, peptide-specific mAb.
2m to Site 2, a region
that potentially overlaps with the CD8 binding site. The strength of
this interaction and the lack of more than a 3-fold effect of any of
the mutants at Site 1 tested to date suggest that the Site 2 interaction functions in the recognition between the NK cell and the
antigen-presenting cell, a trans mode, although it does not
eliminate the possibility of cis interactions between
molecules expressed on the NK cell. Further understanding of the
quantitative contributions of the redistribution of water as binding
takes place will require careful thermodynamic measurements under
conditions that vary the activity of water as solvent.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
To whom correspondence should be addressed: Molecular Biology
Section, LI/NIAID, Bldg. 10, Rm. 11N311, National Institutes of Health,
Bethesda, MD 20892-1892. Tel.: 301-496-6429; Fax: 301-496-0222; E-mail:
dhm@nih.gov.
![]()
ABBREVIATIONS
2m,
2-microglobulin;
mAb, monoclonal
antibody;
MHC, major histocompatibility complex;
TCR, T cell receptor;
scTCR, single-chain T cell receptor;
HIV, human immunodeficiency virus;
MES, 2-(N-morpholino)ethanesulfonic acid.
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Biron, C. A.,
Nguyen, K. B.,
Pien, G. C.,
Cousens, L. P.,
and Salazar-Mather, T. P.
(1999)
Annu. Rev. Immunol.
17,
189-220
2.
Lanier, L. L.
(1998)
Annu. Rev. Immunol.
16,
359-393
3.
Yokoyama, W. M.
(1999)
in
Fundamental Immunology
(Paul, W. E., ed), 4th Ed.
, pp. 575-603, Lippincott-Raven Publishers, Philadelphia
4.
Kärre, K.
(1997)
Immunol. Rev.
155,
5-9
5.
Tormo, J.,
Natarajan, K.,
Margulies, D. H.,
and Mariuzza, R. A.
(1999)
Nature
402,
623-631
6.
Daniels, B. F.,
Karlhofer, F. M.,
Seaman, W. E.,
and Yokoyama, W. M.
(1994)
J. Exp. Med.
180,
687-692
7.
Brennan, J.,
Mager, D.,
Jefferies, W.,
and Takei, F.
(1994)
J. Exp. Med.
180,
2287-2295
8.
Kane, K. P.
(1994)
J. Exp. Med.
179,
1011-1015
9.
Natarajan, K.,
Boyd, L. F.,
Schuck, P.,
Yokoyama, W. M.,
Eilat, D.,
and Margulies, D. H.
(1999)
Immunity
11,
591-601
10.
Chung, D. H.,
Natarajan, K.,
Boyd, L. F.,
Tormo, J.,
Mariuzza, R. A.,
Yokoyama, W. M.,
and Margulies, D. H.
(2000)
J. Immunol.
165,
6922-6932
11.
Matsumoto, N.,
Tajima, K.,
Mitsuki, M.,
and Yamamoto, K.
(2001)
Int. Immunol.
13,
615-623
12.
Mehta, I. K.,
Smith, H. R.,
Wang, J.,
Margulies, D. H.,
and Yokoyama, W. M.
(2001)
Cell. Immunol.
209,
29-41
13.
Hanke, T.,
Takizawa, H.,
McMahon, C. W.,
Busch, D. H.,
Pamer, E. G.,
Miller, J. D.,
Altman, J. D.,
Liu, Y.,
Cado, D.,
Lemonnier, F. A.,
Bjorkman, P. J.,
and Raulet, D. H.
(1999)
Immunity
11,
67-77
14.
Orihuela, M.,
Margulies, D. H.,
and Yokoyama, W. M.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
11792-11797
15.
Correa, I.,
and Raulet, D. H.
(1995)
Immunity
2,
61-71
16.
Matsumoto, N.,
Ribaudo, R. K.,
Abastado, J. P.,
Margulies, D. H.,
and Yokoyama, W. M.
(1998)
Immunity
8,
245-254
17.
Brennan, J.,
Mahon, G.,
Mager, D. L.,
Jefferies, W. A.,
and Takei, F.
(1996)
J. Exp. Med.
183,
1553-1559
18.
Lian, R. H., Li, Y.,
Kubota, S.,
Mager, D. L.,
and Takei, F.
(1999)
J. Immunol.
162,
7271-7276
19.
Sundbäck, J.,
Nakamura, M. C.,
Waldenstrom, M.,
Niemi, E. C.,
Seaman, W. E.,
Ryan, J. C.,
and Kärre, K.
(1998)
J. Immunol.
160,
5971-5978
20.
Waldenstrom, M.,
Sundbäck, J.,
Olsson-Alheim, M. Y.,
Achour, A.,
and Kärre, K.
(1998)
Eur. J. Immunol.
28,
2872-2881
21.
Matsumoto, N.,
Yokoyama, W. M.,
Kojima, S.,
and Yamamoto, K.
(2001)
J. Immunol.
166,
4422-4428
22.
Matsumoto, N.,
Mitsuki, M.,
Tajima, K.,
Yokoyama, W. M.,
and Yamamoto, K.
(2001)
J. Exp. Med.
193,
147-158
23.
Michaelsson, J.,
Achour, A.,
Rolle, A.,
and Kärre, K.
(2001)
J. Immunol.
166,
7327-7334
24.
Li, H.,
Natarajan, K.,
Malchiodi, E. L.,
Margulies, D. H.,
and Mariuzza, R. A.
(1998)
J. Mol. Biol.
283,
179-191
25.
Shields, M. J.,
Moffat, L. E.,
and Ribaudo, R. K.
(1998)
Mol. Immunol.
35,
919-928
26.
Corr, M.,
Boyd, L. F.,
Padlan, E. A.,
and Margulies, D. H.
(1993)
J. Exp. Med.
178,
1877-1892
27.
Kozlowski, S.,
Corr, M.,
Takeshita, T.,
Boyd, L. F.,
Pendleton, C. D.,
Germain, R. N.,
Berzofsky, J. A.,
and Margulies, D. H.
(1992)
J. Exp. Med.
175,
1417-1422
28.
Takeshita, T.,
Takahashi, H.,
Kozlowski, S.,
Ahlers, J. D.,
Pendleton, C. D.,
Moore, R. L.,
Nakagawa, Y.,
Yokomuro, K.,
Fox, B. S.,
Margulies, D. H.,
et al..
(1995)
J. Immunol.
154,
1973-1986
29.
Nagasawa, R.,
Gross, J.,
Kanagawa, O.,
Townsend, K.,
Lanier, L. L.,
Chiller, J.,
and Allison, J. P.
(1987)
J. Immunol.
138,
815-824
30.
Yokoyama, W. M.,
Jacobs, L. B.,
Kanagawa, O.,
Shevach, E. M.,
and Cohen, D. I.
(1989)
J. Immunol.
143,
1379-1386
31.
Takei, F.
(1983)
J. Immunol.
130,
2794-2797
32.
Takei, F.,
Brennan, J.,
and Mager, D. L.
(1997)
Immunol. Rev.
155,
67-77
33.
Roland, J.,
and Cazenave, P. A.
(1992)
Int. Immunol.
4,
699-706
34.
Mason, L. H.,
Ortaldo, J. R.,
Young, H. A.,
Kumar, V.,
Bennett, M.,
and Anderson, S. K.
(1995)
J. Exp. Med.
182,
293-303
35.
Sentman, C. L.,
Hackett, J., Jr.,
Kumar, V.,
and Bennett, M.
(1989)
J. Exp. Med.
170,
191-202
36.
Ozato, K.,
Mayer, N.,
and Sachs, D.
(1982)
Transplantation
34,
113-120
37.
Margulies, D. H.,
Evans, G. A.,
Ozato, K.,
Camerini-Otero, R. D.,
Tanaka, K.,
Appella, E.,
and Seidman, J. G.
(1983)
J. Immunol.
130,
463-470
38.
Polakova, K.,
Plaksin, D.,
Chung, D. H.,
Belyakov, I. M.,
Berzofsky, J. A.,
and Margulies, D. H.
(2000)
J. Immunol.
165,
5703-5712
39.
Plaksin, D.,
Polakova, K.,
McPhie, P.,
and Margulies, D. H.
(1997)
J. Immunol.
158,
2218-2227
40.
Corr, M.,
Slanetz, A. E.,
Boyd, L. F.,
Jelonek, M. T.,
Khilko, S.,
al-Ramadi, B. K.,
Kim, Y. S.,
Maher, S. E.,
Bothwell, A. L.,
and Margulies, D. H.
(1994)
Science
265,
946-949
41.
Sawicki, M. W.,
Dimasi, N.,
Natarajan, K.,
Wang, J.,
Margulies, D. H.,
and Mariuzza, R. A.
(2001)
Immunol. Rev.
181,
52-65
42.
Merritt, E. A.,
and Bacon, D. J.
(1997)
Methods Enzymol.
277,
505-524
43.
Fremont, D. H.,
Matsumura, M.,
Stura, E. A.,
Peterson, P. A.,
and Wilson, I. A.
(1992)
Science
257,
919-927
44.
Madden, D. R.
(1995)
Annu. Rev. Immunol.
13,
587-622
45.
Ribaudo, R. K.,
and Margulies, D. H.
(1995)
J. Immunol.
155,
3481-3493
46.
Chung, D. H.,
Dorfman, J.,
Plaksin, D.,
Natarajan, K.,
Belyakov, I. M.,
Hunziker, R.,
Berzofsky, J. A.,
Yokoyama, W. M.,
Mage, M. G.,
and Margulies, D. H.
(1999)
J. Immunol.
163,
3699-3708
47.
Quiocho, F. A.,
Wilson, D. K.,
and Vyas, N. K.
(1989)
Nature
340,
404-407
48.
Ladbury, J. E.
(1996)
Chem. Biol.
3,
973-980
49.
Ceman, S., Wu, S.,
Jardetzky, T. S.,
and Sant, A. J.
(1998)
J. Exp. Med.
188,
2139-2149
50.
Gurlo, T.,
Meng, W. S.,
Bui, H. H.,
Haworth, I. S.,
and von Grafenstein, H.
(1999)
Immunol. Lett.
70,
139-141
51.
McFarland, B. J.,
Beeson, C.,
and Sant, A. J.
(1999)
J. Immunol.
163,
3567-3571
52.
Wilson, N.,
Fremont, D.,
Marrack, P.,
and Kappler, J.
(2001)
Immunity
14,
513-522
53.
Rudolph, M. G.,
Speir, J. A.,
Brunmark, A.,
Mattsson, N.,
Jackson, M. R.,
Peterson, P. A.,
Teyton, L.,
and Wilson, I. A.
(2001)
Immunity
14,
231-242
54.
Stoneman, E. R.,
Bennett, M., An, J.,
Chesnut, K. A.,
Wakeland, E. K.,
Scheerer, J. B.,
Siciliano, M. J.,
Kumar, V.,
and Mathew, P. A.
(1995)
J. Exp. Med.
182,
305-313
55.
Nicholls, A.,
Sharp, K. A.,
and Honig, B.
(1991)
Proteins
11,
281-296
56.
Kraulis, P. J.
(1991)
J. Appl. Crystallogr.
24,
946-950
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
L. Deng, S. Cho, E. L. Malchiodi, M. C. Kerzic, J. Dam, and R. A. Mariuzza Molecular Architecture of the Major Histocompatibility Complex Class I-binding Site of Ly49 Natural Killer Cell Receptors J. Biol. Chem., June 13, 2008; 283(24): 16840 - 16849. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Kaiser, J. C. Pizarro, J. Kerns, and R. K. Strong Structural basis for NKG2A/CD94 recognition of HLA-E PNAS, May 6, 2008; 105(18): 6696 - 6701. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Lavender, H. H. Chau, and K. P. Kane Distinctive Interactions at Multiple Site 2 Subsites by Allele-Specific Rat and Mouse Ly49 Determine Functional Binding and Class I MHC Specificity J. Immunol., November 15, 2007; 179(10): 6856 - 6866. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Benoit and R. Tan Xenogeneic beta2-Microglobulin Substitution Affects Functional Binding of MHC Class I Molecules by CD8+ T Cells J. Immunol., September 15, 2007; 179(6): 3588 - 3595. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Adams, Z. S. Juo, R. T. Venook, M. J. Boulanger, H. Arase, L. L. Lanier, and K. C. Garcia Structural elucidation of the m157 mouse cytomegalovirus ligand for Ly49 natural killer cell receptors PNAS, June 12, 2007; 104(24): 10128 - 10133. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Back, A. Chalifour, L. Scarpellino, and W. Held Stable masking by H-2Dd cis ligand limits Ly49A relocalization to the site of NK cell/target cell contact PNAS, March 6, 2007; 104(10): 3978 - 3983. [Abstract] [Full Text] |